CardioDx has hired Andrew Guggenhime as its new chief financial officer and Mark Monane as its chief medical officer.
Guggenhime has more than decade of experience as a CFO for various firms. Most recently, he served as CFO for Gilead Sciences subsidiary Calistoga Pharmaceuticals.
Monane was managing director of equity research for Needham & Company for 11 years, and before that he was senior director of medical policy and practices at Medco Health Solutions.